Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AAHI, ACTG, admission, agonist, Alaska, Ave, Bankr, bankrupt, binomial, Bloomberg, bore, CAMT, carcinogenic, CG, Chapter, circumstance, conducive, contemporaneously, contrary, coupon, cyberthreat, Distinguishing, dramatically, DRJ, DSCSA, edge, excise, extinguished, extinguishment, Exyte, fault, FDORA, Ferring, Fort, Fousek, freestanding, FSMC, geopolitical, gu, HCW, hookworm, illegitimate, imidazoquinolinone, impasse, IPC, kick, LadRx, latent, lattice, LMIC, lot, Lynch, malaria, misrepresented, mode, multivalent, mutable, mutagenic, NEJM, numerator, organizational, parking, PDMA, PDUFA, PHI, pichia, Poison, preempted, prejudgment, premarket, presumption, PSA, radiosurgery, rechallenge, redeem, registry, replevin, reply, reproduction, resiquimod, Schuyler, searchable, sequester, shortfall, Slight, specialist, spoilage, successor, Tex, text, theory, tied, tiered, trace, transcription, tree, Ukraine, unconditionally, unexercisable, unnecessary, upstate, varicella, violative, wholesale, Xencor, zoster
Removed:
acutely, African, aggressive, albumin, appellate, appointment, aspect, Chase, Circuit, contrast, cyber, decided, died, expired, Fox, half, harnessing, infusion, integration, intraperiod, mediated, merged, opened, optimized, participated, path, peripheral, preceding, principle, proven, Pty, ratably, Ratification, reacquiring, simplifying, simultaneously, stimulation, strike, Sudunagunta, surface, unearned, unopposed, unspecified, Vice
Filing tables
Filing exhibits
Related press release
IBRX similar filings
Filing view
External links
Exhibit 21.1
SUBSIDIARIES OF IMMUNITYBIO, INC.
Name of Subsidiary | Jurisdiction of Organization | Percentage of Voting Securities Owned Directly or Indirectly by ImmunityBio, Inc. | ||||||||||||
Infacell Therapeutics, Inc. | Delaware | 100.0% | ||||||||||||
Inex Bio, Inc. | Republic of Korea | 100.0% | ||||||||||||
NantCell, Inc. | Delaware | 100.0% | ||||||||||||
Etubics Corporation | Delaware | 100.0% | ||||||||||||
Altor BioScience, LLC | Delaware | 100.0% | ||||||||||||
Altor BioScience Manufacturing Company, LLC | Delaware | 100.0% | ||||||||||||
Receptome, Inc. | Delaware | 100.0% | ||||||||||||
VBC Holdings LLC | Delaware | 92.0% | ||||||||||||
VivaBioCell, S.p.A. | Italy | 100.0% | ||||||||||||
GlobeImmune, Inc. | Delaware | 69.1% | ||||||||||||
Immunotherapy NANTibody, LLC | Delaware | 60.0% | ||||||||||||
IgDraSol, Inc. | Delaware | 100.0% | ||||||||||||
MCLR Parent LLC | Delaware | 100.0% | ||||||||||||
Mariposa Clinic Co LLC | Delaware | 100.0% | ||||||||||||
Mariposa Lab Co LLC | Delaware | 100.0% | ||||||||||||
Mariposa Radiology Co LLC | Delaware | 100.0% | ||||||||||||
AccessBio LLC | Delaware | 50.0% |
__________
Note: All of the subsidiaries shown above are included in our consolidated financial statements. Inactive subsidiaries have not been included in the above list.